Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Synlogic stock

Learn how to easily invest in Synlogic stock.

Synlogic Inc is a biotechnology business based in the US. Synlogic shares (SYBX) are listed on the NASDAQ and all prices are listed in US Dollars. Synlogic employs 84 staff and has a trailing 12-month revenue of around $1.9 million.

How to buy shares in Synlogic

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SYBX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Synlogic stock price (NASDAQ: SYBX)

Use our graph to track the performance of SYBX stocks over time.

Synlogic shares at a glance

Information last updated 2022-09-25.
Latest market close$0.95
52-week range$0.83 - $3.20
50-day moving average $1.03
200-day moving average $1.60
Wall St. target price$7.60
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.97

Buy Synlogic shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Synlogic stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Synlogic price performance over time

Historical closes compared with the close of $0.95 from 2022-09-30

1 week (2022-09-23) -1.04%
1 month (2022-09-02) -9.52%
3 months (2022-07-01) -10.38%
6 months (2022-03-31) -60.42%
1 year (2021-10-01) -68.33%
2 years (2020-10-02) -52.74%
3 years (2019-10-02) 2.02
5 years (2017-09-29) 19.015

Synlogic financials

Revenue TTM $1.9 million
Gross profit TTM $1.8 million
Return on assets TTM -26.21%
Return on equity TTM -51.05%
Profit margin 0%
Book value $1.67
Market capitalisation $67.4 million

TTM: trailing 12 months

Synlogic share dividends

We're not expecting Synlogic to pay a dividend over the next 12 months.

Have Synlogic's shares ever split?

Synlogic's shares were split on a 1:7 basis on 28 August 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Synlogic shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Synlogic shares which in turn could have impacted Synlogic's share price.

Synlogic share price volatility

Over the last 12 months, Synlogic's shares have ranged in value from as little as $0.826 up to $3.2. A popular way to gauge a stock's volatility is its "beta".

SYBX.US volatility(beta: 1.28)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Synlogic's is 1.2837. This would suggest that Synlogic's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Synlogic overview

Synlogic, Inc. , a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate to treat homocystinuria; SYNB2081 to lower uric acid for the potential treatment of gout; and SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase I clinical trial for the treatment of enteric hyperoxaluria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the research and pre-clinical development of a synthetic biotic medicine for the treatment of inflammatory bowel disease; and Ginkgo Bioworks, Inc.

Frequently asked questions

What percentage of Synlogic is owned by insiders or institutions?
Currently 9.717% of Synlogic shares are held by insiders and 58.686% by institutions.
How many people work for Synlogic?
Latest data suggests 84 work at Synlogic.
When does the fiscal year end for Synlogic?
Synlogic's fiscal year ends in December.
Where is Synlogic based?
Synlogic's address is: 301 Binney Street, Cambridge, MA, United States, 02142
What is Synlogic's ISIN number?
Synlogic's international securities identification number is: US87166L1008
What is Synlogic's CUSIP number?
Synlogic's Committee on Uniform Securities Identification Procedures number is: 60470J103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site